We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+0.37%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.8B
AUM Growth
-$20.8M
Cap. Flow
+$57.1M
Cap. Flow %
3.18%
Top 10 Hldgs %
23.87%
Holding
255
New
12
Increased
107
Reduced
96
Closed
12

Top Buys

Rank Stock Value
1
GDDY icon
GoDaddy
GDDY
+$28M
2
UPWK icon
Upwork
UPWK
+$20.6M
3
G icon
Genpact
G
+$18.4M
4
FOUR icon
Shift4
FOUR
+$10.2M
5
SRAD icon
Sportradar
SRAD
+$8.21M

Sector Composition

Rank Sector Weight
1 Healthcare 31.73%
2 Technology 29.93%
3 Industrials 16.4%
4 Consumer Discretionary 7.95%
5 Communication Services 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OABI icon
101
OmniAb
OABI
$286M
$4M 0.22%
2,547,255
+146,167
+6% +$264K
OR icon
102
OR Royalties Inc
OR
$5.5B
$3.95M 0.22%
103,810
-11,918
-10% -$489K
EHC icon
103
Encompass Health
EHC
$11.6B
$3.9M 0.22%
40,338
+1,940
+5% +$199K
DY icon
104
Dycom Industries
DY
$12.1B
$3.87M 0.22%
11,414
-372
-3% -$140K
DORM icon
105
Dorman Products
DORM
$4.23B
$3.86M 0.22%
37,017
-530
-1% -$63.1K
OPRX icon
106
OptimizeRx
OPRX
$120M
$3.78M 0.21%
601,921
+11,247
+2% +$104K
IPGP icon
107
IPG Photonics
IPGP
$3.53B
$3.71M 0.21%
32,356
+2,932
+10% +$318K
TTEK icon
108
Tetra Tech
TTEK
$8.67B
$3.7M 0.21%
122,955
+27,117
+28% +$959K
AMPH icon
109
Amphastar Pharmaceuticals
AMPH
$878M
$3.67M 0.2%
187,348
+66,172
+55% +$1.62M
MIR icon
110
Mirion Technologies
MIR
$4.13B
$3.66M 0.2%
196,899
-2,953
-1% -$66.6K
LNTH icon
111
Lantheus
LNTH
$6.62B
$3.55M 0.2%
46,850
+2,202
+5% +$158K
ODD icon
112
ODDITY Tech
ODD
$779M
$3.53M 0.2%
+264,020
New +$6.62M
IRMD icon
113
iRadimed
IRMD
$1.23B
$3.49M 0.19%
36,289
-704
-2% -$70.4K
CGNX icon
114
Cognex
CGNX
$10B
$3.49M 0.19%
71,232
+12,901
+22% +$602K
FIBK icon
115
First Interstate BancSystem
FIBK
$3.7B
$3.47M 0.19%
103,949
-2,859
-3% -$102K
VCYT icon
116
Veracyte
VCYT
$4.46B
$3.44M 0.19%
106,665
-1,477
-1% -$54.7K
FLOC
117
Flowco Holdings
FLOC
$790M
$3.42M 0.19%
165,802
+3,009
+2% +$65.2K
HWKN icon
118
Hawkins
HWKN
$2.98B
$3.35M 0.19%
21,796
-333
-2% -$48.7K
ICLR icon
119
Icon
ICLR
$13.9B
$3.34M 0.19%
30,146
+18,175
+152% +$2.48M
MTSI icon
120
MACOM Technology Solutions
MTSI
$19.2B
$3.26M 0.18%
14,700
-2,138
-13% -$477K
DCO icon
121
Ducommun
DCO
$2.71B
$3.22M 0.18%
26,413
ENSG icon
122
The Ensign Group
ENSG
$10.5B
$3.2M 0.18%
15,898
-214
-1% -$41.9K
RMBS icon
123
Rambus
RMBS
$9.73B
$3.19M 0.18%
37,059
-7,886
-18% -$787K
HCSG icon
124
Healthcare Services Group
HCSG
$1.58B
$3.16M 0.18%
170,112
VITL icon
125
Vital Farms
VITL
$592M
$3.14M 0.18%
222,523
+37,223
+20% +$880K

Similar funds

Rice Hall James & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Rice Hall James & Associates held 255 positions worth $1.8B, down 1.1% from $1.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates deployed $57.1M of net new capital in Q1 2026, opening 12 new positions and adding to 107 existing holdings. Its largest new stake was Upwork: 1,308,167 shares worth $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Amicus Therapeutics, an estimated $39.3M trimmed.

  • Rice Hall James & Associates's largest Q1 2026 buy was Upwork: 1,308,167 shares worth $14.3M.
  • Rice Hall James & Associates added most to GoDaddy in Q1 2026, an estimated $28M increase.
  • Rice Hall James & Associates's biggest Q1 2026 reduction was Amicus Therapeutics, cutting an estimated $39.3M.
  • Rice Hall James & Associates fully exited iShares Micro-Cap ETF in Q1 2026, selling an estimated $4.53M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.8B portfolio in Q1 2026.
  • Rice Hall James & Associates opened 12 new positions and closed 12 in Q1 2026.
  • Rice Hall James & Associates's portfolio value fell 1.1% quarter-over-quarter to $1.8B.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.